245 related articles for article (PubMed ID: 18725839)
1. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
[TBL] [Abstract][Full Text] [Related]
2. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
4. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
[TBL] [Abstract][Full Text] [Related]
5. A national survey of primary care physicians' methods for screening for fecal occult blood.
Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
[TBL] [Abstract][Full Text] [Related]
6. Improving colorectal cancer screening in family medicine: an Oklahoma Physicians Resource/Research Network (OKPRN) study.
Scheid DC; Hamm RM; Ramakrishnan K; McCarthy LH; Mold JW;
J Am Board Fam Med; 2013; 26(5):498-507. PubMed ID: 24004701
[TBL] [Abstract][Full Text] [Related]
7. Predictors of colorectal cancer screening in diverse primary care practices.
Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
[TBL] [Abstract][Full Text] [Related]
8. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.
Klabunde CN; Lanier D; Nadel MR; McLeod C; Yuan G; Vernon SW
Am J Prev Med; 2009 Jul; 37(1):8-16. PubMed ID: 19442479
[TBL] [Abstract][Full Text] [Related]
10. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
[TBL] [Abstract][Full Text] [Related]
11. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
12. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.
Nadel MR; Berkowitz Z; Klabunde CN; Smith RA; Coughlin SS; White MC
J Gen Intern Med; 2010 Aug; 25(8):833-9. PubMed ID: 20383599
[TBL] [Abstract][Full Text] [Related]
13. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
[TBL] [Abstract][Full Text] [Related]
14. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.
Turner B; Myers RE; Hyslop T; Hauck WW; Weinberg D; Brigham T; Grana J; Rothermel T; Schlackman N
J Gen Intern Med; 2003 May; 18(5):357-63. PubMed ID: 12795734
[TBL] [Abstract][Full Text] [Related]
15. Barriers to full colon evaluation for a positive fecal occult blood test.
Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
[TBL] [Abstract][Full Text] [Related]
16. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of complete diagnostic examination in clinical practice settings.
Jimbo M; Meyer B; Hyslop T; Cocroft J; Turner BJ; Weinberg DS; Myers RE
Cancer Detect Prev; 2006; 30(6):545-51. PubMed ID: 17113240
[TBL] [Abstract][Full Text] [Related]
18. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
19. Are physicians' recommendations for colorectal cancer screening guideline-consistent?
Yabroff KR; Klabunde CN; Yuan G; McNeel TS; Brown ML; Casciotti D; Buckman DW; Taplin S
J Gen Intern Med; 2011 Feb; 26(2):177-84. PubMed ID: 20949328
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of colorectal cancer screening in a large medical organization.
Hawley ST; Vernon SW; Levin B; Vallejo B
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):314-9. PubMed ID: 14973108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]